AAAAAA

   
Results: 1-9 |
Results: 9
EPSTEIN-BARR-VIRUS-INDUCED INTERSTITIAL NEPHRITIS IN AN HIV-POSITIVE PATIENT WITH PROGRESSIVE RENAL-FAILURE
Authors: FRAZAO JM ELANGOVAN L FELSENFELD AJ STANLEY TM COHEN AH
Citation: Jm. Frazao et al., EPSTEIN-BARR-VIRUS-INDUCED INTERSTITIAL NEPHRITIS IN AN HIV-POSITIVE PATIENT WITH PROGRESSIVE RENAL-FAILURE, Nephrology, dialysis, transplantation, 13(7), 1998, pp. 1849-1852
INTERMITTENT ORAL 1-ALPHA-HYDROXYVITAMIN D2 IS EFFECTIVE AND SAFE FORTHE SUPPRESSION OF SECONDARY HYPERPARATHYROIDISM IN HEMODIALYSIS-PATIENTS
Authors: FRAZAO JM CHESNEY RW COBURN JW
Citation: Jm. Frazao et al., INTERMITTENT ORAL 1-ALPHA-HYDROXYVITAMIN D2 IS EFFECTIVE AND SAFE FORTHE SUPPRESSION OF SECONDARY HYPERPARATHYROIDISM IN HEMODIALYSIS-PATIENTS, Nephrology, dialysis, transplantation, 13, 1998, pp. 68-72
USE OF ONE-ALPHA-HYDROXYVITAMIN D-2 (1-ALPHA-D-2) IN 121 HEMODIALYSIS-PATIENTS WITH SECONDARY HYPERPARATHYROIDISM - A PHASE-3 TRIAL
Authors: FRAZAO JM COBURN JW CHESNEY RW
Citation: Jm. Frazao et al., USE OF ONE-ALPHA-HYDROXYVITAMIN D-2 (1-ALPHA-D-2) IN 121 HEMODIALYSIS-PATIENTS WITH SECONDARY HYPERPARATHYROIDISM - A PHASE-3 TRIAL, Journal of the American Society of Nephrology, 8, 1997, pp. 2671-2671
SAFETY OF MAGNESIUM LAXATIVES IN DIALYSIS PATIENTS
Authors: FRAZAO JM COBURN JW
Citation: Jm. Frazao et Jw. Coburn, SAFETY OF MAGNESIUM LAXATIVES IN DIALYSIS PATIENTS, Seminars in dialysis, 10(5), 1997, pp. 292-292
EFFICACY AND SAFETY OF INTERMITTENT ORAL 1-ALPHA(OH) VITAMIN-D-2 IN SUPPRESSING 2-DEGREES HYPERPARATHYROIDISM IN HEMODIALYSIS-PATIENTS
Authors: FRAZAO JM LEVINE BS TAN AU MAZESS RB KYLLO DM KNUTSON JC BISHOP CW COBURN JW
Citation: Jm. Frazao et al., EFFICACY AND SAFETY OF INTERMITTENT ORAL 1-ALPHA(OH) VITAMIN-D-2 IN SUPPRESSING 2-DEGREES HYPERPARATHYROIDISM IN HEMODIALYSIS-PATIENTS, Dialysis & transplantation, 26(9), 1997, pp. 583
CARBAMYLATED HEMOGLOBIN IN PRERENAL AZOTEMIA
Authors: FRAZAO JM BARTH RH BERLYNE GM
Citation: Jm. Frazao et al., CARBAMYLATED HEMOGLOBIN IN PRERENAL AZOTEMIA, Nephron, 71(2), 1995, pp. 153-155
PERSISTENCE OF ANTIBODIES TO HEPATITIS-C VIRUS IN A CHRONIC-HEMODIALYSIS POPULATION
Authors: CARRERA F SILVA JG OLIVEIRA C FRAZAO JM PIRES C
Citation: F. Carrera et al., PERSISTENCE OF ANTIBODIES TO HEPATITIS-C VIRUS IN A CHRONIC-HEMODIALYSIS POPULATION, Nephron, 68(1), 1994, pp. 38-40
ONE-YEAR EVOLUTION OF ANTI-HCV ANTIBODY IN A HEMODIALYSIS POPULATION
Authors: SILVA JG OLIVEIRA C FRAZAO JM PIRES C CARRERA F
Citation: Jg. Silva et al., ONE-YEAR EVOLUTION OF ANTI-HCV ANTIBODY IN A HEMODIALYSIS POPULATION, Kidney international, 44(6), 1993, pp. 1448-1448
VIRAL-HEPATITIS AND HEPATIC-DYSFUNCTION - ANALYSIS OF A HBSAG+ HEMODIALYSIS POPULATION
Authors: SILVA JG FRAZAO JM OLIVEIRA C PIRES C CARRERA F
Citation: Jg. Silva et al., VIRAL-HEPATITIS AND HEPATIC-DYSFUNCTION - ANALYSIS OF A HBSAG+ HEMODIALYSIS POPULATION, Kidney international, 44(6), 1993, pp. 1448-1448
Risultati: 1-9 |